Skip to main content
. 2016 Aug 31;16(6):399–406. doi: 10.1007/s40256-016-0185-0

Fig. 5.

Fig. 5

Different effects of the angiotensin-converting enzyme inhibitor perindopril and the angiotensin receptor blocker losartan on factors influencing thrombus formation [3739]. NS not significant, PAI-1 plasminogen activator inhibitor-1, t-PA tissue plasminogen activator